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The effect of AA on contractile function of adult ventricular myocytes is also unclear. AA has been shown to enhance cell shortening (CS) and the Ca 2ϩ transient in ARVM (10) or to reduce CS in adult guinea pig ventricular myocytes (36) . It also has been reported that AA mediates a biphasic effect of TNF-␣ on contraction and the Ca 2ϩ transient in ARVM (1) . Regardless, results from measurements of cardiac contractile function do not correlate well with the above-mentioned electrophysiological findings.
We (38) previously showed that during activation of Ca 2ϩ -independent PLA 2 , hydrolysis of membrane plasmalogen phospholipids causes an increase in AA release and lysoplasmenylcholine (LPlasC) accumulation (38) . It was then demonstrated that exposure to LPlasC exerts a positive inotropic and an arrhythmogenic effect on adult rabbit ventricular myocytes by enhancing Ca 2ϩ transients and I Ca,L (34) . Thus it is important to know what the effect is of AA on the electrical and contractile function of adult ventricular myocytes. This study was designed to determine the effect of exposure of ARVM to extracellular AA on I Ca,L , CS, and the Ca 2ϩ transient. I found that exposure to AA directly altered the voltage dependence of gating properties of L-type Ca 2ϩ channel and thereby reduced I Ca,L , which accounts for AA inhibition of contraction and the Ca 2ϩ transient in ARVM.
METHODS

Ventricular myocyte preparation.
Single ventricular myocytes were isolated from hearts of adult male Sprague-Dawley rats (250 -300 g) by using enzymatic dissociation as described previously (34) . Briefly, rats were deeply anesthetized with isoflurane (Vedco, St. Joseph, MO), and hearts were rapidly excised and perfused at 37°C via the aorta with a control buffer solution, followed by enzymatic and mechanical dissociation. Isolated single ARVM were resuspended in culture medium containing antibiotic-free, bicarbonate-buffered culture medium 199 (60%; GIBCO, Grand Island, NY) with 36% Earle's balanced salt solution composed of (in mM) 116 NaCl, 4.7 KCl, 0.9 NaH 2PO4, 0.8 MgSO4, 26 NaHCO3, and 5.6 glucose and containing 4% fetal bovine serum (GIBCO) (pH 7.40 in 5% CO2-95% air at 37°C). After incubation for 3-4 h to allow recovery, ARVM were plated in culture dishes with serum-free culture medium overnight before experiments. Quiescent rod-shaped ARVM with clear striations were used for ICa,L, Ca 2ϩ transient, and CS measurements. All experiments were performed at 36 -37°C. The use of animals was carried out under a protocol approved by the Animal Care and Use Committee at the University of Arkansas for Medical Sciences.
Measurement of ICa,L. Whole cell ICa,L of ARVM was measured in Na ϩ -and K ϩ -free solutions with 2 mM Ca 2ϩ with the use of conventional whole cell patch techniques (15) using a patch-clamp amplifier (Axopatch 200A; Axon Instruments, Foster City, CA) as described previously (34) . Briefly, patch electrodes were filled with the following pipette solution and had a tip resistance typically of 1-3 M⍀. The pipette solution consisted of (in mM) 100 CsOH, 70 aspartate, 11 CsCl, 15 tetraethylammonium chloride, 2 MgC1 2, 5 MgATP, 5 EGTA, 0.1 CaC1 2, 5 pyruvic acid, 5.6 glucose, 5 Tris2-phosphocreatine, 0.4 Li 4-GTP, and 10 HEPES/Tris (pH adjusted to 7.20 with CsOH). The bath solution contained (in mM) 145 N-methyl-D-glucamine chloride, 0.8 MgC12, 2 CaC12, 2 4-aminopyridine, and 10 HEPES/Tris (pH adjusted to 7.40 with CsOH) to minimize membrane currents associated with Na ϩ and K ϩ . The time-dependent effect of AA on I Ca,L was assessed by applying 160-or 200-ms single voltage pulses to ϩ10 mV from a holding potential (E h) of Ϫ70 mV every 15 s or double pulses to ϩ10 mV with a depolarization of E h to Ϫ40 mV for ϳ400 ms before application of the second pulse. The kinetics of I Ca,L inactivation were analyzed using a double-exponential
, where f and s are the fast and slow time constants, respectively, and A x is the amplitude scalar. The current-voltage (I-V) relationship of I Ca,L was constructed by applying 250-ms voltage pulses to potentials between Ϫ60 and ϩ60 mV from an Eh of Ϫ70 mV in 10-mV increments at 0.2 Hz. The voltage dependence of steady-state inactivation and activation of I Ca,L were determined using a gapped double-pulse protocol; a 1-s prepulse to potentials between Ϫ90 and ϩ60 mV was followed by a 10-ms return to the holding potential and then a fixed 250-ms test pulse to ϩ10 mV every 10 s. All raw data obtained for steady-state inactivation and activation and for the kinetics of ICa,L inactivation were fit to the Boltzmann distribution and a double-exponential function, respectively, using the nonlinear least-squares curve-fitting algorithm in Origin software (OriginLab, Northampton, MA).
After the whole cell configuration was achieved, a period of 10 -15 min was allowed before the experiment so that rundown of ICa,L was minimal. Series resistance was 3-6 M⍀ and electronically compensated (Ն90%), whereas the recorded currents were filtered at 1-2 kHz and sampled at 5 kHz using pCLAMP 8.0 software (Axon Instruments). The current density of I Ca,L in each myocyte was obtained by normalizing the current amplitude to membrane capacitance (C m) that was calculated from uncompensated capacity current transients recorded in response to 5-mV hyperpolarizing pulses from the holding potential.
Contractile function or CS. Unloaded CS of intact ARVM was elicited and measured as described previously (34) . Briefly, CS was elicited by field stimulation (1-2 ms in duration, 1.5-fold threshold voltage) at 0.5 Hz in normal Tyrode's solution containing (in mM) 140 NaCl, 5.4 KCl, 1 CaCl2, 0.8 MgCl2, 10 HEPES/Tris, and 5.6 glucose (pH 7.40 at 37°C). CS was monitored with a video edgemotion detector system (Crescent Electronics, Sandy, UT). Data for CS were not expressed as percentages of original cell length, because the degree of CS could be affected by the degree of cell attachment to the dish. The measured parameters of contractile function in single ARVM included the peak magnitude of CS and rise time and decay time (duration between 10 and 90% of the peak amplitude) during contraction and relaxation, respectively. The protocol of post-rest potentiation (PRP) was used as an indicator to estimate Ca 2ϩ handling by the sarcoplasmic reticulum (SR) (3, 52) . PRP30 was measured as the ratio of the amplitude of the first potentiated contraction after a 30-s rest interval to that of the steady-state CS before the rest.
Measurement of intracellular free Ca 2ϩ concentration. Intracellular free Ca 2ϩ concentration in ventricular myocytes was measured as described previously (34) . Briefly, ventricular myocytes seeded on 25-mm coverslips in culture medium were loaded with 2 M fura-PE3 AM for 30 min in a culture incubator at 37°C. Myocytes were then transferred to a perfusion chamber on the stage of an inverted microscope (Nikon TE300; Irving, TX) and superfused with normal Tyrode's solution. After subtraction of the background signal, Ca 2ϩ signals were recorded as an intensity ratio (R or F340/F380), i.e., the fluorescent intensity excited at 340 nm (F340) divided by that at 380 nm (F380). In some experiments, myocyte contraction was recorded simultaneously with Ca 2ϩ transients when the cells were illuminated with a halogen lamp (Nikon) through a long-wavelength pass filter (640 nm; Chroma).
Chemicals. Fura-PE3 AM was purchased from TEFLABS (Austin, TX). AA, fatty acid-free BSA, and other reagents were purchased from Sigma Chemical (St. Louis, MO). The stock solutions of AA (1 M) and indomethacin (0.1 M) were made in 100% ethanol. The stock solution of nordihydroguaiaretic acid (NDGA; 1 M) was prepared in dimethyl sulfoxide (DMSO). The final concentration of ethanol and DMSO in experimental control solutions (i.e., Na ϩ -, K ϩ -free and 2 mM Ca 2ϩ solution) was Ͻ 0.01% and had no significant effect on ICa,L (data not shown).
Statistics. In all experiments, data recorded in response to AA were compared with that of the steady-state control or the level in the presence of metabolic inhibitors before exposure to AA in each individual cell. Thus data are expressed as a percentage or fraction of each control value before combining for statistical analysis. Values are means Ϯ SE. Statistical significance (P Ͻ 0.05) was evaluated using Student's paired t-test or one-way ANOVA with Duncan's multiple range test (when more than two conditions were compared).
RESULTS
Effect of AA on whole cell I Ca,L in ventricular myocytes.
The acute effect of AA on I Ca,L was first examined by monitoring peak I Ca,L elicited by repeatedly applying a single 160-ms voltage pulse to ϩ10 mV from an E h of Ϫ70 mV (Fig. 1A , inset) before, during, and after exposure to AA in superfusion solutions. In some experiments, I-V curves were obtained before and during exposure to AA. Figure 1A shows that AA elicited a concentration-dependent inhibition of peak I Ca,L . In this cell, the amplitude of I Ca,L was reduced to 87% of the control level after 9 -10 min in the presence of 1 M AA. Upon exposure to 10 M AA, I Ca,L was transiently increased by ϳ8% in the first couple of minutes, followed by a decrease to 33% of the control level. The transient increase in I Ca,L was observed in ϳ60% of tested cells (Fig. 1A) . Table 1 shows summarized data of concentration-dependent effects of AA on the amplitude and time constants of I Ca,L inactivation. To examine the voltage-dependent block of AA, cells were given a double 160-ms test pulse to ϩ10 mV every 15 s from two different holding potentials; i.e., after the first test pulse, E h was switched from Ϫ70 mV to Ϫ40 mV before the second test pulse (Fig. 1B, inset) . Figure 1B shows that AA-induced inhibition of I Ca,L was enhanced when cells were voltageclamped at Ϫ40 mV. This phenomenon became more evident at higher concentrations of 3 and 10 M AA (Table 1) , suggesting a voltage-dependent block of L-type Ca 2ϩ channels. Note that exposure to 100 M AA caused many cells to become shortened with loss of voltage control within a few minutes. Thus only a few data could be obtained, and the values shown in Table 1 could underestimate the maximal effect of 100 M AA on I Ca,L . Figure 2A shows estimated half-maximum inhibitory concentration (IC 50 ) of AA by plotting the amplitude of I Ca,L induced by AA relative to the control as a function of AA concentrations. Raw data were best fit with the Hill equation with a fixed Hill coefficient of 1 (dashed lines). The estimated value for IC 50 of AA effects at E h of Ϫ70 and Ϫ40 mV was 8.5 and 5.8 M, respectively. Table 1 also shows that AA elicited a concentration-dependent increase in both time constants of I Ca,L inactivation at two E h values. Note that in the presence of 100 M AA, inactivation of I Ca,L became single exponential because of markedly reduced magnitudes.
The voltage dependence of peak I Ca,L was assessed before and during exposure to AA when inhibition reached a pseudosteady state (i.e., the gap in each trace in Fig. 1 ). Figure 2B shows that AA elicited a concentration-dependent reduction in the maximum current density of I Ca,L y with a small leftward shift in the maximum peak I Ca,L to 0 mV from ϩ10 mV (Fig.  2B) . Figure 3A shows that AA caused a significant leftward (hyperpolarizing) shift in the voltage dependence of I Ca,L activation curve by shifting the half-maximum activation potential (V h ) from Ϫ8.0 Ϯ 0.3 mV (control, n ϭ 7) to Ϫ19.3 Ϯ 0.4 mV (n ϭ 3) in the presence of 10 M AA with no effect on the slope factor (control, 5.3 Ϯ 0.3 mV/e-fold change; 10 M AA, 5.6 Ϯ 0.4 mV). Meanwhile, AA decreased the maximum conductance (i.e., control G max , 0.25 Ϯ 0.1 pS/pF; 1 M AA, 0.23 Ϯ 0.2 pS/pF; 10 M AA, 0.06 Ϯ 0.1 pS/pF). As shown in Fig. 3B , AA also caused a marked hyperpolarizing shift in I Ca,L inactivation curve 12 min after exposure. The result shows that 10 M AA shifted V h to Ϫ44.9 Ϯ 0.9 mV (n ϭ 3) from Ϫ21.1 Ϯ 0.5 mV in the absence of AA (n ϭ 7) with no effect on the slope factor (control, 4.7 Ϯ 0.2 mV; 10 M AA, 5.4 Ϯ 0.8 mV). These data suggest that AA-induced changes in gating properties of I Ca,L can account for its voltage-dependent inhibition on Ca 2ϩ channels. Extracellular site for AA-induced inhibition of I Ca,L : effect of BSA. To determine the site of action for AA-induced suppression of Ca 2ϩ channels, BSA was used to remove AA from the cell membrane because of its high binding capacity and affinity for AA (6) . Figure 4A shows that after reduction in the presence of 10 M AA, I Ca,L recovered slowly and partially to 59% of the control level at 10 min after AA removal. Subsequent switch to a superfusion solution containing 0.1% BSA resulted in a rapid and complete recovery of I Ca,L . Figure 4B shows that I Ca,L was reduced to 38% of control 6 min after exposure to 10 M AA. Addition of 0.1% BSA in the presence of AA completely reversed the inhibition of I Ca,L induced by AA. Note that BSA also reversed the AA-induced change in I Ca,L inactivation kinetics (Fig. 4B, inset) . The reversible effect of BSA on AA-induced changes in I Ca,L was also observed at an E h of Ϫ40 mV and in two other experiments. Figure 4B also shows that removal of BSA in the presence of AA resumed inhibition of I Ca,L induced by AA in 6 min. These results suggest that AA acts on L-type Ca 2ϩ channel at an extracellular site.
To further determine whether cytosolic metabolism of AA plays any role in its action on I Ca,L , myocytes were internally equilibrated for 15-20 min with a AA-containing pipette solution. In these experiments, only one concentration of AA (3 M) was used in the pipette solution to minimize possible damage to cells. Figure 5A shows that the maximum current density of I Ca,L was not significantly altered by intracellular application of 3 M AA. However, there was a slight depolarizing shift in the I-V curve of I Ca,L . This change could result from a depolarizing shift in the I Ca,L activation curve to a V h of Ϫ1.3 Ϯ 2.0 mV (n ϭ 3) in contrast to a V h of Ϫ8.0 Ϯ 0.3 mV in the absence of AA in the pipette solution (Fig. 5B) . Neither the slope factor of the activation curve (5.9 Ϯ 0.7 vs. 5.3 Ϯ 0.3 mV in control) nor the voltage dependence of the inactivation curve of I Ca,L was significantly altered under these conditions. These results show that intracellular application of AA had an effect on I Ca,L gating opposite to that induced by extracellular AA. Regardless, extracellular exposure to 10 M AA elicited the same inhibitory effect on I Ca,L in myocytes intracellularly loaded with 3 M AA (Fig. 5C) . In this experiment, after an initial transient increase, I Ca,L was reduced to 42 and 34% of control levels at E h of Ϫ70 and Ϫ40 mV, respectively. Similar results were observed in two other experiments. This supports the suggestion that AA reduces I Ca,L primarily by acting at the extracellular side of the cell membrane.
Effects of indomethacin and NDGA on AA-induced inhibition of I Ca,L . The direct effect of AA on Ca 2ϩ channel activities has been demonstrated in the presence of inhibitors of AA metabolism (20, 35, 41, 44, 53) . The effect of AA on I Ca,L was then examined in myocytes that were exposed to 10 -20 M indomethacin 3-7 min before and during exposure to AA. Indomethacin (20 M) alone had no statistically significant effect on peak I Ca,L . Under these conditions, AA also reduced peak I Ca,L in a concentration-dependent and voltage-dependent manner ( Fig. 6A) with IC 50 at two E h , comparable to those in the absence of indomethacin. Figure 6C summarizes the effect of AA on I Ca,L inactivation kinetics in the presence of indomethacin. These results show that indomethacin had no effect on basal or AA-induced changes in the kinetics of I Ca,L inactivation. Figure 7A shows effects of AA on I Ca,L in a myocyte that was first exposed to 20 M indomethacin and subsequently to 20 M indomethacin and 10 M NDGA. Under these conditions, NDGA slightly reduced I Ca,L that was further reduced following a transient increase after exposure to 10 M AA. The reduction in I Ca,L by 26 Ϯ 3% (n ϭ 9) elicited by 10 M NDGA was similar to findings by others (27) . The summarized data show that NDGA had no effect on AA-induced concentration-and voltage-dependent suppression of I Ca,L (Fig. 7B) or increase in time constants of I Ca,L inactivation (Fig. 7C) .
Effect of AA on contractility and the Ca 2ϩ transient of intact adult ventricular myocytes. The effect of AA on unloaded contractile function of ARVM was first examined in myocytes under physiological conditions in the absence of fluorescent Ca 2ϩ -sensitive dye. The PRP30 protocol was applied before and during application of AA. Figure 8A shows that exposure to 1 M AA caused a small decrease in CS in one myocyte (top) and a small increase in another myocyte (bottom). In contrast, CS was markedly reduced by 3 M AA (Fig. 8A, top) and completely stopped by 10 M AA (bottom). Upon removal of AA, CS recovered to 75-80% of control in 80% of tested cells depending on exposure durations of AA. Figure 8B demonstrates the effect of BSA on AA-induced suppression of CS. In this experiment, after CS was stopped by 30 M AA, addition of 0.1% BSA restored CS with an overshoot in the presence of AA. Upon subsequent removal of BSA, AA suppressed CS again, consistent with BSA effect on AAinduced suppression of I Ca,L . The same results were obtained in three other experiments. The effect of AA on the Ca 2ϩ transient was also examined in myocytes loaded with fura-PE3 AM (Fig. 8C ). AA at 1 M caused a slight reduction in the amplitude of Ca 2ϩ transients that was markedly suppressed after the concentration of AA was increased to 3 M (Fig. 8C,  top) . When exposed to 10 M AA, the Ca 2ϩ transient was completely blocked after an initial transient rise (Fig. 8C,  bottom) . Inhibitory effects of AA on CS and Ca 2ϩ transients are summarized in Fig. 8D , in which the amplitudes of CS and Ca 2ϩ transients presented were obtained from traces 30 s before the magnitude could be measured accurately. AA at 10 M completely inhibited CS (n ϭ 9) and Ca 2ϩ transients (n ϭ 7) in all tested cells in 2-6 min. Figure 8D also shows that PRP30 of CS and the Ca 2ϩ transient was not significantly altered in the presence of different concentrations of AA, suggesting no significant effect on SR function. Figure 9A shows a representative recording of simultaneous measurements of CS and the Ca 2ϩ transient in the same myocyte before and during exposure to 1 and 10 M AA. Individual traces of CS and the Ca 2ϩ transient of the myocyte in control, at 5 min in the presence of 1 M AA, and before cessation in the presence of 10 M AA are shown in Fig. 9B . Figure 9C shows a phase-plane plot of contraction as a function of simultaneously measured Ca 2ϩ transients, both of which were normalized to each peak magnitude. This relationship allows a prediction of a change in myofilament sensitivity to Ca 2ϩ (34) . The difference in relative free Ca 2ϩ level (the peak of the loop) at peak CS was Ͻ5% in the absence and presence of 10 M AA. This indicates that AA does not significantly alter the Ca 2ϩ sensitivity of myofilaments. Therefore, AA-induced negative inotropy most likely results from reduction of I Ca,L .
DISCUSSION
When AA is released to the extracellular space in response to stimuli via PLA 2 activation (12, 33, 37), it acts on cells in an autocrine and paracrine fashion (7, 11) . The effect of extracellular AA on cardiac basal L-type Ca 2ϩ channel and contractile function remain controversial and unclear. This study demonstrated that 1) extracellular AA induced a voltage-dependent block of I Ca,L by altering gating properties (IC 50 of 8.5 M at E h of Ϫ70 mV), 2) extracellular application of BSA com- pletely and reversibly blocked AA-induced changes in I Ca,L and CS; 3) intracellular application of AA had no significant effect on I Ca,L or the inhibitory effect induced by extracellular AA, 4) inhibitors of AA metabolism had no effect on AAinduced inhibition of I Ca,L , and 5) AA suppressed CS and Ca 2ϩ transients of intact ARVM.
Inhibition of I Ca,L induced by AA. The present study showed that exposure to AA (Ͻ100 M) reduced I Ca,L with no change in the holding current at E h of Ϫ70 or Ϫ40 mV (Figs. 1 and  5-7) . The recovery of I Ca,L upon AA removal was facilitated by BSA (Fig. 4) . Thus AA-induced inhibitory effect on I Ca,L is not nonspecific and consistent with findings reported by others (16, 30, 35, 46, 49) . The voltage-dependent inhibition of I Ca,L induced by AA suggests that AA interferes with both the closed state (i.e., at Ϫ70 mV) and inactivated state (i.e., at Ϫ40 mV) of L-type Ca 2ϩ channels. This voltage-dependent block is supported by the fact that AA caused a hyperpolarizing shift in the steady-state inactivation of I Ca,L , which resulted in 70 and 7% reduction in channel availability at Ϫ40 and Ϫ70 mV, respectively. The AA-induced reduction of macroscopic I Ca,L presented is compatible with its reduction in open probability of single-channel activity of L-type Ca 2ϩ channel with an increase in the number of nulls observed in rat sympathetic neurons (31) . Moreover, AA (at 10 M) elicited a hyperpolarizing shift in V h of I Ca,L activation curve (Fig. 3A) , which is accountable for the initial transient increase in I Ca,L (Fig. 2B) . Interestingly, similar transient increase before inhibition of Ba 2ϩ current and hyperpolarizing shift in the I-V curve induced by AA were observed in sympathetic neurons (30) . The AAinduced decrease in amplitude of I Ca,L is consistent with findings in neonatal and adult ventricular myocytes reported previously by other investigators (36, 41, 49) . However, those studies showed less inhibition of I Ca,L induced by AA (e.g., Ͻ50% at 10 M) than the present study and did not determine inactivation (B) of ICa,L were determined using a gapped double-pulse protocol; a 1-s prepulse to potentials between Ϫ90 and ϩ60 mV was followed by a 10-ms return to the holding potential and then a fixed 250-ms test pulse to ϩ10 mV. Raw data were fit by the Boltzmann distribution to obtain half-maximum activation or inactivation potential (Vh) and the slope factor by using the nonlinear leastsquares curve-fitting algorithm. Data are means Ϯ SE. G/Gmax, normalized conductance; I/Imax, normalized inactivated current. the effect of AA on gating properties of basal I Ca,L (36, 41, 49) . In noncardiac cells, AA was also shown to decrease L-type (30), T-type (46) and N-type Ca 2ϩ channels (30) , indicative of AA acting on primarily the ␣ 1 -subunit of Ca 2ϩ channels. The present study showed that AA slowed I Ca,L inactivation with a stronger effect on f in a voltage-dependent manner. This could be due to greater relief of Ca 2ϩ -dependent inactivation of I Ca,L and/or a smaller degree of voltage-dependent inactivation at more negative potentials (14) . In fact, inactivation of I Ca,L that transiently increases is faster than those of reduced I Ca,L in the presence of 10 M AA under the same voltage conditions (data not shown). Thus relief of Ca Direct action at the extracellular site. BSA, a protein that does not cross the cell membrane, has been widely used to identify membrane receptor-mediated nongenomic actions of estrogen (39) . BSA also is known to have multiple binding sites (6, 42) with a K d of 16 nM for AA (6) . Thus the antagonizing effect of BSA on AA-induced changes in I Ca,L is attributable to BSA dissociation of AA from the surface of the cell membrane. The present study showed that extracellular BSA not only facilitates the recovery of I Ca,L following AA removal but also reversibly abolished AA-induced suppression of I Ca,L and CS (Figs. 4B and 8B) . With the molar ratio of AA (10 -30 M) to BSA (15 M), BSA can remove AA rapidly (22) and thereby leave no partition of AA to the cell membrane (42) . Thus these results strongly suggest that AA acts on ion channels primarily at the extracellular side of the cell membrane (30, 35) .
If inhibition of I Ca,L induced by extracellular application of AA were mediated by AA metabolites, one would expect that internal load cells with AA would yield the same or stronger inhibitory effect than extracellular AA. This is apparently not the case, because internal application of AA had no effect on basal I Ca,L amplitude or the inhibitory effect induced by extracellular AA (Fig. 5) . Interestingly, internal application of AA altered I Ca,L activation curve, a small effect opposite to that induced by extracellular AA, indicating a site-specific action of AA on Ca 2ϩ channels. When applied extracellularly, the hydrocarbon tail of AA incorporates readily into the hydrophobic domains of the membrane or channel because of its amphipathic property. This would increase membrane fluidity and disorder as expected from four cis carbon double bounds of AA. Membrane fluidity has been shown to increase steeply when AA is increased from 10 to 100 M (2). This can account for the membrane disruption observed at 100 M AA described previously in the present study. In addition, the carboxylic head of AA can interact with hydrophilic head groups of the membrane or the polar portion of the channel. Thus AA could alter readily the configuration of membrane microdomains containing Ca 2ϩ channels via hydrophilic (e.g., when the channel is opened) and hydrophobic (i.e., closed-and inactivated-state block) pathways as proposed for free polyunsaturated fatty acids interacting with cardiac Na ϩ channels (24) . Moreover, the pH gradient across the cell membrane can affect the distribution of unionized form and the degree of hydrophobicity of AA within the cell membrane. This can account at least in part for the site-specific direct effect of AA on Ca 2ϩ channels. In addition, neither indomethacin nor NDGA affects extracellular AA-induced changes in I Ca,L , suggesting no involvement of AA metabolites. Together, these results strongly suggest that AA-induced inhibition of I Ca,L is mediated by its direct action primarily on the proximity of the extracellular side of the cell membrane.
It has been reported that a certain percentage of long-chain fatty acids (including AA) could release protons to the cytosol, thereby causing a transient acidification (22, 23) . A study using nonsuperfused, quiescent ARVM and neonatal cardiomyocytes reported an intracellular acidification by 0.42 pH unit 20 min after exposure to 10 M AA (48) . The sustained intracellular acidification reported in that study is, however, unexpected, because such acidification should be recovered by effective pH regulatory mechanisms and buffer capacity (28, 32, 47) . Nevertheless, decreased intracellular pH either has no effect (26) or causes a small hyperpolarizing shift in voltage-dependent gating of I Ca,L (e.g., by 2.0 pH units) (21) . Thus a transient Negative inotropy and inhibition of Ca 2ϩ transients induced by AA. AA-induced inhibition of I Ca,L would lead to suppression of excitation-contraction (E-C) coupling in intact cardiac myocytes. The present study showed that concentration-dependent suppression of CS and Ca 2ϩ transients with an initial increase before cessation (at high concentrations) parallels the observed biphasic change in I Ca,L described above. The response of CS and the Ca 2ϩ transient to AA stimulation is relatively more rapid than that of I Ca,L , primarily due to well-established voltage, ionic, and buffer control to optimize I Ca,L measurement under patch clamping. My results showing AA-induced suppression of the Ca 2ϩ transient are also comparable to those observed in neonatal cardiomyocytes (18) in which, however, complete inhibition was achieved at 30 M AA. This could result from different lipid composition in the cell membrane between adult and neonatal cardiomyocytes. By contrast, one study (10) in ARVM showed that AA (Ͼ10 M) enhanced CS and Ca 2ϩ transients, which were suggested to be mediated by cyclooxygenase metabolites via PKC-dependent inhibition of K ϩ channels. It is unclear whether this discrepancy could be explained by differences in experimental conditions; e.g., only cells that responded to AA were selected for study (10) . Furthermore, the effect of AA on K ϩ channels is controversial. AA has been shown to block cardiac transient outward current (5) and delayed-rectifier K ϩ channel with IC 50 Ͼ 20 M (19) or to enhance cloned human inwardrectified K ϩ channel (35) and K ϩ current in guinea pig ventricular myocytes (36) . Thus the effect of AA-induced change in K ϩ channels on the action potential and CS is still unclear. Moreover, although AA metabolites acting in concert on Ca 2ϩ channels could facilitate inhibition of E-C coupling, inhibitors of AA metabolism were shown to have no effect on AAinduced suppression of Ca 2ϩ transients (18) or CS (36) . Thus the AA-induced suppression of CS and the Ca 2ϩ transient is most consistent with its direct inhibition of I Ca,L .
The present study also found no apparent change in relaxation kinetics or PRP of CS and Ca 2ϩ transients induced by AA (Fig. 8) , suggesting no significant effect on SR function. This result is also consistent with findings of no effect of AA on Ca 2ϩ uptake of the Ca 2ϩ pump in isolated cardiac SR vesicles (13) or single-channel activity of ryanodine receptor Ca 2ϩ release channels in planar lipid bilayer (45) . In addition, although there was a trend of reduction in the Ca 2ϩ sensitivity of myofilaments (Fig. 9C) , it was too small to account for the negative inotropic effect of AA. Together, these findings indicate that AA-induced negative inotropy parallels its suppression of the Ca 2ϩ transient, primarily resulting from its direct inhibition of I Ca,L .
Physiological and pathophysiological relevance and significance. AA is liberated from membrane phospholipids primarily via activation of PLA 2 s (12) under pathophysiological conditions such as in response to thrombin (4), acetylcholine (9), hypoxia (38) , inflammation (40, 51) , and myocardial ischemia (8) . We (33) have previously shown that AA is released to culture medium in response to stimulation by IL-1␤ and TNF-␣, cytokines closely associated with inflammation-and injury-mediated changes in brain and cardiac function (29, 43) . The released AA, which could readily reach the levels used in the present study (7), directly acts on membrane targets such as ion channels in an autocrine/paracrine fashion. Meanwhile, after reentering the cell, AA can be oxidized to various eicosanoid metabolites that alter various cellular functions (7, 11) . During hypoxia or ischemia, the direct action of AA on membrane proteins becomes more dominant because of low oxygen tension. We (33, 37, 38) previously showed that LPlasC accumulation occurs concomitantly with AA release under hypoxia or cytokine stimulation. We (34) also showed that LPlasC increases I Ca,L and SR function, thereby inducing arrhythmias in ventricular myocytes. The direct inhibitory effect of AA on I Ca,L can counterbalance the deleterious effect of LPlasC to prevent intracellular Ca 2ϩ overload and consequently protect the cell from injury. Thus AA and -6 polyunsaturated free fatty acids have been considered as antiarrhythmic agents (36, 49) . Similarly, AA counteracting the stimulatory effect of ␤-adrenergic stimulation (36, 41) can also be cardiac protective. However, high concentrations of AA (e.g., Ն100 M) become cytotoxic because of disruption of membrane integrity.
